Tick-borne diseases are more than just Lyme Disease

 Tick-borne diseases are increasing in incidence. 

 More than 300,000 people in the United States are diagnosed with Lyme disease, the most common tick-borne disease, each year. Patients infected  with Borrelia burgdorferi, the causative agent of Lyme disease, may also co-infected with another tick-borne disease causing organism, suck as Babesia microti.

According to the Centers for Disease Control and Prevention, state and local health departments in 2017 have reported a record number of cases of tickborne disease. 

Selected Tickborne Diseases Reported to CDC, U.S., 2016

Reported Tickborne Disease, US20162017
Lyme Disease (confirmed and probable)36,42942,743
Anaplasmosis/Ehrlichiosis5,7507,718
SPotted Fever Rickettsiosis4,2696,248
Babesiosis1,9102,368
Tularemia230239
Powassan virus2233
Total48,61059,349

 

Heat maps of Selected Tickborne Diseases Reported to CDC, U.S., 2016

NOTE: Each dot represents one case. Cases are reported from the infected person’s county of residence, not necessarily the place where they were infected.

NOTE: In 2016, no cases of tickborne illness were reported from Hawaii. In 2016, Alaska reported 6 travel-related cases of Lyme disease and 1 case of tularemia.

NOTE: During 2016, Babesiosis was reportable in Alabama, Arkansas, California, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New York, North Dakota, Ohio, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin, and Wyoming.

NOTE: Anaplasmosis and ehrlichiosis were not reportable in Colorado, Idaho, New Mexico, Alaska, Hawaii in 2016.

NOTE: Spotted fever Rickettsiosis was not reportable in Alaska and Hawaii in 2016.

Discerning the correct diagnosis can be challenging and lengthy. The CDC recommends a two-tier serological testing methodology that relies on the detection of antibodies. While these guidelines are effective in many situations, serological tests are known to be insensitive during the first few weeks of infection. Also, it is specific to Lyme disease and does not address other tick-borne diseases. 

Advances in technology such as Polymerase Chain Reaction (PCR) allow for the potential detection of tick-borne organisms before anitbody responses are detectable. Testing technology combines serology for B. burgdorferi (Lyme) and PCR testing for Borrelia species* and may offer a greater opportunity to detect evidence of infection, since serology alone may be insensitive in the first few weeks, ** PCR also provides the opportunity to detect other tick-borne infections. 

Regional testing reflects disease epidemiology. 

The incidence of different tick-borne disease varies by area, that is why it is important to tailor testing to regional needs. Feel confident providing patients with fast, comprehensive testing to detect infections caused by ticks in your area.

Tick-Borne Infection Analysis: North Coast

Polymerase chain Reaction (PCR) detection for 
  • Borrelia species:

    • B. miyamotoi
    • B. burgdorferi (Lyme)
  • Babesia microti
  • Anaplasma phagocytophilum
  • Ehrlichia chaffeensis

Anitbody capture (IgM, IgG and IgA) EIA for detection of antibody to B. burgdorferi.

Why Partner With ESCL

With 70 years of experience serving the Rhode Island, Southeastern Massachusetts  and Eastern Connecticut area, we know there are  some of the most beautiful parks and beaches in the country. But, according to statistics compiled by the Centers for Disease Control and Prevention, given those states’ small sizes, there was a relatively high incidence of confirmed Lyme Disease cases in 2016, as compared to other states. 

East Side Clinical Laboratory is proud to partner with Accutix to provide physicians with the latest generation of tick-borne disease testing for both acutely and chronically ill patients. 

Because your patients should be enjoying the outdoors, not worrying about their health, they deserve the most sensitive and specific testing available. East Side Clinical Laboratory offers a broad menu of seasonal testing, including: 

  • Blood Parasite Smear (ordering code 7504) 
  • Rocky Mountain Spotted Fever (Rickettsia) (ordering code 6944) 
  • West Nile Virus (ordering code 9588) 
  • Influenza (ordering code 5106) 
  • Pertussis (ordering code 5027) 

Acute Tick-Borne Disease

Ultra-Sensitive Latest Generation Testing

Acute Phase Tick-Borne Disease (TBD) Analysis- Lyme, Babesia, Anaplasma, Ehrlichia (HME), and B. miyamotoi

  • Most Sensitive and Specific Tests for Identifying Tick-Borne Infections in Acutely ill Patients
    • Polymerase Chain Reaction (PCR) for Babesia, Anaplasma, Ehrlichia (HME),and Borrelia species 
    • Antibody Capture (IgM, IgG, IgA) for Early Antibody to B. burgdorferi
  • Latest Generation Assays Provide Higher Sensitivity and Specificity 
  • Identifies Co-Infected Patients
  • Early Diagnosis of all Common Tick-Borne Diseases
  • Early Evidence-Based Treatment Decisions 
  • Rapid Turnaround Time 
  • Cost Effective
  • One Specimen, One Lab

Because getting it right is so important.

Order CodeTest Name
11000Lyme Antibody Analysis (LAA)
4264TBD-4 (Lyme serology; Babesia, Anaplasma, Ehrlichia PCR)1
16804TBD-4M (lyme serology; Borrelia [burgdorferi + miyamotoi], Babesia, Anaplasma, Ehrlichia PCR)1
4263TBD-3 (Lyme serology; Babesia, Anaplasma PCR)1
5604TICK (ID ONLY)2
5612TICK (with reflex to Lyme PCR)2
5613TICK (with reflex to Babesia Microti PCR)2

1Specimen Requirement: 5.0 EDTA Whole Blood (Lavender Top Tube)
2Specimen Requirement: Place Tick/Insect into a Sterile Container.

For more information, please call 800.479.5227